Manning & Napier Group’s LLY Holdings & Trades

First Buy
Q2 2013
Duration Held
50 Quarters
Largest Add
Q2 2015
+4.42 M Shares
Current Position
55 Shares
$41,965 Value

Manning & Napier Group's LLY Position Overview

Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 55 shares of Eli Lilly and Company (LLY) worth $41,965, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.

Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in LLY, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 4.42 M shares. Largest reduction occurred in Q4 2015, reducing 4.08 M shares.

Analysis based on 13F filings available since 2013 Q2

Manning & Napier Group's Eli Lilly and Company (LLY) Holding Value Over Time

Track share changes against reported price movement

Quarterly Eli Lilly and Company (LLY) Trades by Manning & Napier Group

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2013 +185,463 Add 0.00% 185,462 $49.11
Q3 2013 +429 Add 0.23% 185,891 $50.33
Q4 2013 -64,051 Reduce 34.46% 121,840 $50.99
Q1 2014 +3,004 Add 2.47% 124,844 $58.86
Q2 2014 +32,311 Add 25.88% 157,155 $62.16
Q3 2014 -9,037 Reduce 5.75% 148,118 $64.85
Q4 2014 +3,364 Add 2.27% 151,482 $68.99
Q1 2015 -1,899 Reduce 1.25% 149,583 $72.64
Q2 2015 +4.42 M Add 2957.39% 4.57 M $83.49
Q3 2015 -458,640 Reduce 10.03% 4.11 M $83.69
Q4 2015 -4.08 M Reduce 99.10% 36,950 $84.22
Q1 2016 -6,210 Reduce 16.81% 30,740 $71.96
Q2 2016 -7,974 Reduce 25.94% 22,766 $78.71
Q3 2016 -2,780 Reduce 12.21% 19,986 $80.16
Q4 2016 +2,230 Add 11.16% 22,216 $73.46
Q1 2017 +5,061 Add 22.78% 27,277 $84.06
Q2 2017 -2,475 Reduce 9.07% 24,802 $82.25
Q3 2017 -1,725 Reduce 6.96% 23,077 $85.50
Q4 2017 +16,728 Add 0.00% 16,727 $84.41
Q1 2018 +70 Add 0.42% 16,797 $77.28
Q2 2018 +142,366 Add 847.57% 159,163 $85.32
Q3 2018 +11,450 Add 7.19% 170,613 $107.30
Q4 2018 +9,045 Add 5.30% 179,658 $115.71
Q1 2019 +27,825 Add 15.49% 207,483 $129.76
Q2 2019 -207,483 Sold Out 207,483 $0.00
Q1 2020 +178,048 New Buy 178,048 $138.71
Q2 2020 +17,293 Add 9.71% 195,341 $164.17
Q3 2020 +3,919 Add 2.01% 199,260 $148.01
Q4 2020 -15,122 Reduce 7.59% 184,138 $168.82
Q1 2021 +6,208 Add 3.37% 190,346 $186.81
Q2 2021 -190,346 Sold Out 190,346 $0.00
Q4 2024 +657 New Buy 657 $772.00
Q1 2025 -657 Sold Out 657 $0.00
Q3 2025 +55 New Buy 55 $763.00

Manning & Napier Group's Eli Lilly and Company Investment FAQs

Manning & Napier Group first purchased Eli Lilly and Company (LLY) in Q2 2013, acquiring 185,462 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Manning & Napier Group has held Eli Lilly and Company (LLY) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Manning & Napier Group's largest addition to Eli Lilly and Company (LLY) was in Q2 2015, adding 4,573,337 shares worth $381.83 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 55 shares of Eli Lilly and Company (LLY), valued at approximately $41,965. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Manning & Napier Group's peak holding in Eli Lilly and Company (LLY) was 4,573,337 shares, as reported at the end of Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.